Published in BJU Int on November 12, 2009
Controversies on individualized prostate cancer care: gaps in current practice. Ther Adv Urol (2013) 0.76
The osteoblastic and osteoclastic interactions in spinal metastases secondary to prostate cancer. Cancer Growth Metastasis (2013) 0.76
Investigation of risk factors for prostate cancer patients with bone metastasis based on clinical data. Exp Ther Med (2010) 0.75
Associations of Prostate-Specific Antigen, Prostate Carcinoma Tissue Gleason Score, and Androgen Receptor Expression with Bone Metastasis in Patients with Prostate Carcinoma. Med Sci Monit (2017) 0.75
Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am J Surg (2008) 2.43
NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells. Cancer Res (2008) 2.01
Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging. J Magn Reson Imaging (2010) 1.87
Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer. Clin Cancer Res (2004) 1.58
Primary omental gastrointestinal stromal tumor (GIST). World J Surg Oncol (2007) 1.39
The relationship between FDG uptake in PET scans and biological behavior in breast cancer. Breast Cancer (2007) 1.23
Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer. Prostate (2003) 1.19
Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. J Clin Endocrinol Metab (2012) 1.17
A comparison of interobserver reproducibility of Gleason grading of prostatic carcinoma in Japan and the United States. Arch Pathol Lab Med (2005) 1.15
Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis. Cancer Sci (2011) 1.11
Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3. Int J Cancer (2002) 1.11
Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol Int (2002) 1.10
Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma. Pathol Int (2005) 1.09
Protein expression, gene amplification, and mutational analysis of EGFR in triple-negative breast cancer. Breast Cancer (2012) 1.06
Gastric schwannomas show an obviously increased fluorodeoxyglucose uptake in positron emission tomography: report of two cases. Surg Today (2011) 1.05
Two cases of breast cancer with cartilaginous and osseous metaplasia. Breast Cancer (2005) 1.04
PKC theta, a novel immunohistochemical marker for gastrointestinal stromal tumors (GIST), especially useful for identifying KIT-negative tumors. Pathol Int (2005) 1.03
Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in stage I adenocarcinomas of the lung. Pathol Int (2002) 1.00
Immunohistochemical evaluation for hormone receptors in breast cancer: a practically useful evaluation system and handling protocol. Breast Cancer (2006) 0.99
Cellular composition of subacute thyroiditis. an immunohistochemical study of six cases. Pathol Res Pract (2002) 0.98
Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer. BMC Cancer (2013) 0.97
Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer. BMC Cancer (2010) 0.97
Expression of bone morphogenetic protein-7 (BMP-7) in human prostate. Prostate (2004) 0.97
High expression of Ran GTPase is associated with local invasion and metastasis of human clear cell renal cell carcinoma. Int J Cancer (2008) 0.97
Clinicopathological significance of ASC amino acid transporter-2 expression in pancreatic ductal carcinoma. Histopathology (2014) 0.94
Immunohistochemical analysis of 14-3-3 sigma and related proteins in hyperplastic and neoplastic breast lesions, with particular reference to early carcinogenesis. Pathol Int (2004) 0.93
Keratin 17 expression correlates with tumor progression and poor prognosis in gastric adenocarcinoma. Ann Surg Oncol (2012) 0.92
Possible role of the RhoC/ROCK pathway in progression of clear cell renal cell carcinoma. Biomed Res (2008) 0.91
A case of mesenteric cystic lymphangioma in an adult which caused duodenal stenosis after resection. Int J Surg Case Rep (2012) 0.90
Immunohistochemical expression of 14-3-3 sigma protein in various histological subtypes of uterine cervical cancers. Pathol Int (2004) 0.90
Renal metanephric adenoma mimicking papillary renal cell carcinoma on computed tomography: a case report. Urol Int (2012) 0.90
Lymph node lesion in adult-onset Still's disease resembling peripheral T-cell lymphoma: a report of three cases. Int J Surg Pathol (2002) 0.89
Usefulness of prostate-specific antigen velocity in screening for prostate cancer. Int J Urol (2002) 0.88
The role of M2 muscarinic receptor subtypes mediating contraction of the circular and longitudinal smooth muscle of the pig proximal urethra. J Urol (2002) 0.88
Comparison of evaluations for hormone receptors in breast carcinoma using two manual and three automated immunohistochemical assays. Am J Clin Pathol (2007) 0.88
Urodynamic effects of silodosin, a new alpha 1A-adrenoceptor selective antagonist, for the treatment of benign prostatic hyperplasia. Neurourol Urodyn (2010) 0.88
Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma. Cancer Sci (2014) 0.88
Management of benign prostatic hyperplasia with silodosin. Open Access J Urol (2009) 0.87
Prevalence, viral load, and physical status of HPV 16 and 18 in cervical adenosquamous carcinoma. Virchows Arch (2009) 0.87
Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma. BMC Cancer (2013) 0.86
Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma. Hepatol Res (2014) 0.86
The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with prostate specific antigen levels of 4.1-10.0 ng/mL. Cancer (2002) 0.86
Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia. Int J Urol (2004) 0.86
Neoadjuvant weekly paclitaxel with and without trastuzumab in locally advanced or metastatic breast cancer. Anticancer Res (2009) 0.86
Diagnostic usefulness of ¹⁸F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma. Eur J Nucl Med Mol Imaging (2013) 0.86
Up-regulation of a BCL9-related beta-catenin-binding protein, B9L, in different stages of sporadic colorectal adenoma. Cancer Sci (2007) 0.86
Comparison of L-type amino acid transporter 1 expression and L-[3-18F]-α-methyl tyrosine uptake in outcome of non-small cell lung cancer. Nucl Med Biol (2010) 0.86
Single minimum incision endoscopic radical nephrectomy for renal tumors with preoperative virtual navigation using 3D-CT volume-rendering. BMC Urol (2010) 0.85
Triple-negative breast cancer: histological subtypes and immunohistochemical and clinicopathological features. Cancer Sci (2011) 0.85
The Rho-kinase inhibitor HA-1077 suppresses proliferation/migration and induces apoptosis of urothelial cancer cells. BMC Cancer (2014) 0.85
Centroblastic and centroblastic/centrocytic lymphoma associated with a prominent epithelioid granulomatous response: a clinicopathologic study of 50 cases. Mod Pathol (2002) 0.85
Increased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasis. BMC Cancer (2007) 0.85
[A case report: testicular pure seminoma metastasized to costal bone after 2 years post-operatively]. Hinyokika Kiyo (2004) 0.84
Immunological significance of the accumulation of autophagy components in oral squamous cell carcinoma. Cancer Sci (2014) 0.84
Luteinizing hormone (LH)-releasing hormone agonist reduces serum adrenal androgen levels in prostate cancer patients: implications for the effect of LH on the adrenal glands. J Androl (2012) 0.84
Immunohistochemical expression of the beta-catenin-interacting protein B9L is associated with histological high nuclear grade and immunohistochemical ErbB2/HER-2 expression in breast cancers. Cancer Sci (2007) 0.83
Dilated cardiomyopathy as a presenting feature of Cushing's syndrome. Intern Med (2013) 0.83
Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer. Breast Cancer (2011) 0.82
Local control by breast-conserving surgery with nipple resection. Anticancer Res (2005) 0.82
Bizarre parosteal osteochondromatous proliferation of the maxilla: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol (2012) 0.82
Direct regulation of prostate blood flow by vascular endothelial growth factor and its participation in the androgenic regulation of prostate blood flow in vivo. Endocrinology (2004) 0.82
[A case of eosinophilic cystitis that was treated with oral suplatast tosilate (IPD-1151T)]. Hinyokika Kiyo (2009) 0.82
Role of beta-adrenoceptor subtypes in mediating relaxation of the pig bladder trigonal muscle in vitro. Neurourol Urodyn (2003) 0.82
Progressive transformation of germinal centers: a clinicopathological study of 42 Japanese patients. Int J Surg Pathol (2003) 0.82
Pathological complete response and prognosis in patients receiving neoadjuvant paclitaxel and trastuzumab with and without anthracyclines for stage II and III, HER2-positive operable breast cancer: a single-institute experience. Anticancer Res (2011) 0.82
Increased alpha-taxilin protein expression is associated with the metastatic and invasive potential of renal cell cancer. Biomed Res (2011) 0.82
Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma. Cancer Immunol Immunother (2011) 0.81
Immunohistochemical demonstration of 14-3-3 sigma protein in normal human tissues and lung cancers, and the preponderance of its strong expression in epithelial cells of squamous cell lineage. Pathol Int (2003) 0.81
MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer. Anticancer Res (2002) 0.81
Somatic mutations of the catalytic subunit of cyclic AMP-dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol [Rapid Communication]. Endocr J (2014) 0.81
Protein profiling of blood samples from patients with hereditary leiomyomatosis and renal cell cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Int J Mol Sci (2012) 0.81
Randomized prospective comparison of fosfomycin and cefotiam for prevention of postoperative infection following urological surgery. J Infect Chemother (2007) 0.81
Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer. Exp Ther Med (2011) 0.81
YM155 reverses rapamycin resistance in renal cancer by decreasing survivin. J Cancer Res Clin Oncol (2014) 0.81
Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma. BMC Cancer (2009) 0.81
Efficacy of extended-release tolterodine for the treatment of neurogenic detrusor overactivity and/or low-compliance bladder. Int J Urol (2010) 0.80
Hormonal and morphologic evaluation of the effects of antiandrogens on the blood supply of the rat prostate. Urology (2003) 0.80
A novel splice variant of the nuclear coactivator p120 functions strongly for androgen receptor: characteristic expression in prostate disease. Endocr J (2008) 0.80
Is Stat3 and/or p53 mRNA expression a prognostic marker for renal cell carcinoma? Biomed Res (2009) 0.80
Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population. Anticancer Res (2003) 0.80
Synergistic decline in expressions of p73 and p21 with invasion in esophageal cancers. Cancer Sci (2003) 0.80
Preparation of a single prostate needle biopsy specimen for histological diagnosis and RNA analysis. J Urol (2006) 0.79
[Update of familial prostate cancer in Japan]. Nihon Rinsho (2002) 0.79
MALT type lymphoma demonstrating prominent plasma cell differentiation resembling fibrous variant of Hashimoto's thyroiditis: a three case report. Pathol Oncol Res (2008) 0.79
Novel clusters of highly expressed genes accompany genomic amplification in breast cancers. FEBS Lett (2007) 0.78
[L-type amino acid transporter 1 (LAT1)]. Nihon Rinsho (2012) 0.78
Co-expressed type of ER and HER2 protein as a predictive factor in determining resistance to antiestrogen therapy in patients with ER-positive and HER2-positive breast cancer. Oncol Rep (2005) 0.78